Colonography Versus Colonoscopy in High Risk Patient

NCT ID: NCT00748449

Last Updated: 2011-09-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

39 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-06-30

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

to evaluate the acceptability of CT-colonography compared to colonoscopy for the detection of advanced adenomas in subpopulations at high risk of colorectal.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Secondary objective: to evaluate the medical and economic impact of the implementation of CT- colonography in this setting.Methodology: prospective multicenter randomized controlled trial with direct patient benefitN° of patients to be included: 600 Study follow-up :1 consultation and 3 phone contacts (M1, M6 and M12)Evaluation criteria:Main endpoint: acceptability of the colorectal cancer screening (% of enrolled patients having actually undergone the exploration)Secondary endpoints: - cost/effectiveness ratio of the 2 diagnostic tests with calculation of the economic and medical costs. - number of advanced adenoma detected in each group- number of CRC cases detected in each group

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

CT Colonography

Group Type ACTIVE_COMPARATOR

CT-colonography

Intervention Type PROCEDURE

1 CT-colonography; Procedure/Surgery/Radiation

2

Colonoscopy

Group Type ACTIVE_COMPARATOR

Colonoscopy

Intervention Type PROCEDURE

1 Colonoscopy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Colonoscopy

1 Colonoscopy

Intervention Type PROCEDURE

CT-colonography

1 CT-colonography; Procedure/Surgery/Radiation

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Colonoscopy or CT-colonography

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Surveillance of patients with a personal history of advanced adenoma or CRC:

* Informed consent obtained
* Age ≥ 18 and ≤ 80 years old
* History of advanced adenomatous polyps
* Or history of non metastatic CRC with curative surgery and without other treatment more than 2 years before enrollment.
* Previous medical examination

Screening of patients with a Family history of CRC at high risk:

* Informed consent obtained
* Age ≥ 18 and ≤ 80 years old
* First degree family history of colorectal cancer diagnosed \<60yrs during the five previous years-Previous medical examination

* Colonoscopy with a polyps resection dated more than 5 years and less than 2 years prior to enrollment.
* Enrollment in another protocol
* no health insurance affiliation Family histories
* Age \< 18 or \>80 years old
* Patients with one or several family histories of first degree colorectal cancer occured to unknown age or diagnosed after 60 years old.
* Eligible patients having already undergone colonoscopy screening
* no health insurance affiliation

Exclusion Criteria

Personal histories

* Age \< 18 or \>80 years old
* history of non adenomatous polyps
* history of Metastatic CRC
* familial adenomatous polyposis, Peutz-Jeghers syndrome, hereditary non polyposis colorectal cancer (HNPCC), juvenile polyposis syndrome
* Familial history of familial adenomatous polyposis
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Frederic PRAT, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Assistance Publique - Hôpitaux de Paris

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cochin

Paris, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P051074

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Safe Anastomosis Feasibility Study
NCT05180565 COMPLETED NA